proactive engagement is our priority. what will the landscape look like in 1, 5 and 10 years, what will the challenges and opportunities be as new technologies come into the cancer environment, how will we respond and manage these issues today.
the next decade in healthcare will look nothing like the last. oncology is experiencing a tidal wave of technologies that continues to profoundly change the way cancer is diagnosed, treated, and monitored. the arrival of disruptive technologies like the HEP-C drugs, innovative technologies like CAR-T and precision medicine and emerging technologies like BITE, will drive oncology onward.
as the environment shifts, greater requirements to demonstrate value and improved outcomes will be necessary as questions of affordability will continue to dominate conversations. the need to create a value paradigm for cancer care is of upmost importance and implementing value-based outcomes for cancer care remains a complex challenge, globally. the decisions taken today will have an impact on the landscape over the next decade.
manufacturers, regulators, health care professionals and patient advocates must address a number of topics like education and knowledge and clinical, regulatory, reimbursement and policy hurdles.
“barriers must be overcome to fundamentally manage innovation in oncology and balance value and funding priorities”
CAR-T CELL THERAPY
accelerating adoption through collaboration
overcoming roadblocks to expand access
the cancer collaborative 🐾
want like to learn more about about our projects
send us your question at email@example.com